KER-065

Drug identity checked against registry records

Also recorded as Rinvatercept

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety and Efficacy of KER-065 in Participants With Duchenne Muscular DystrophyNCT07704099KROSPhase 2Recruiting2028-08-26Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.